Qazi Corner, Edition 5: Tofacitinib, Fenofibrates, Pouchitis Guidelines and BLUE-C

The first quarterly issue of 2024 reviews a promising JAK inhibitor for acute severe ulcerative colitis, fenofibrates in PBC, new recommendations from the AGA, and a next generation multi-target DNA stool test for detecting colorectal cancer.

Related Keywords

Ravi Shah ,Jeffrey Schwartz ,Schwartz ,American College Of Gastroenterology ,Colorectal Cancer Awareness ,American College ,New England Journal ,